Manchester University | November 03, 2022
GenXys, the global leader in precision prescribing software with embedded pharmacogenetic (PGx) data, is teaming up with Manchester University (MU) for pharmacogenomics education. Together, GenXys and MU will help drive global awareness and education of PGx-informed prescribing decisions in support of expanding PGx adoption and pending legislation in the U.S., including the Right Drug Dose Now Act. MU, located in northern Indiana, is a leading national academic institution with a strong educational and research stream in pharmacogenetics. With on-campus, online, and dual (PharmD/MS in PGx) degree programs, as well as a Graduate Certificate in PGx, MU typically has an annual PGx enrollment of 60 to 70 students. The partnership will enable GenXys' expertise and proprietary algorithms in genomics and clinical knowledge to support the expansion of genetically informed medication review capabilities in MU's educational and research space. MU will now be able to integrate GenXys' award-winning Clinical Decision Support Systems (CDSS), incorporating PGx with other patient data points through embedded translation and interpretation in specific degree programs. This will lead to students further learning appropriate evidence-based precision prescribing options for patients, ultimately leading to better health outcomes and empowering the next generation of clinicians to seamlessly utilize PGx in patient care. As a national leader in pharmacogenetic and clinical education, Manchester University looks to partner with leading-edge technology companies that further the advancement of PGx for better health outcomes, says David Kisor, PharmD, FCP, Professor of Pharmaceutical Sciences and Pharmacogenomics, Director of Pharmacogenomics at MU. "It is recognized that more than 95 percent of the population has at least one PGx variant, and large percentages of patients receiving medications across therapeutic areas do not respond adequately with an initial medication leading to trial-and-error prescribing. Additionally, the consequences and treatments of adverse drug events may cost more than $30 billion annually in the U.S.," Dr. Kisor adds. "By formally measuring the effect of automatic PGx inclusion in CDSS tools in education as well as incorporating GenXys' precision prescribing platform into our advanced courses, we aim to produce the most knowledgeable and equipped individuals who will apply PGx optimally across healthcare settings. Integration of the precision prescribing platform offered by GenXys into the educational content of MU will accelerate the knowledge uptake of PGx in prescribing decisions for the next generation of clinicians and other healthcare professionals.
"By working with a stellar academic university like MU, we are able to demonstrate the advantage of including PGx in clinical care for clinicians across different career levels ,There are so many advantages to equipping students and trainees with leading-edge tools and knowledge—the future is looking bright for precision medicine!"
Bernard Esquivel, MD, PhD, Chief Medical Officer of GenXys.
Auto-analysis of genetic information with other medication interaction points is helping to transform the centuries-old trial-and-error approach to prescribing to one of accuracy. PGx is all about personalized, safe, and appropriate medication options being available at any point of care. When integrated into smart algorithms with other data points, PGx is a critical part of proactive healthcare delivering precision medicine to everyone and leveling up healthcare inequality. MU is at the educational edge of changing day-to-day healthcare, and the partnership with GenXys is a model of commercial and academic integration that supports pending national legislation to provide better population healthcare, improve patient safety, and reduce healthcare costs.
About GenXys Health Care Systems
GenXys, with a presence across North America, provides the world's most comprehensive precision prescribing solutions with embedded pharmacogenetics to solve one of healthcare's biggest challenges: inappropriate ("trial-and-error") prescribing. GenXys' clinical decision support software suite is in use by major insurance providers, health systems, pharmacies and their pharmacogenetic labs across North America. Ongoing global clinical studies are paving the way into geographical markets to enable GenXys to realize its vision of making every prescription better with its software to increase patient safety, improve population health, and reduce healthcare costs. https://www.genxys.com/
About Manchester University
Manchester University, in North Manchester and Fort Wayne, Ind., provides vibrant and transformative student experiences. Manchester University respects the infinite worth of every individual and graduates persons of ability and conviction who draw upon their education and faith to lead principled, productive, and compassionate lives that improve the human condition.
Magic EdTech | November 30, 2022
Digilangua, a New York-based provider of a digital library of comprehensible novels, has partnered with Magic EdTech to offer an added solution for language teachers. The solution will empower educators with digital access to their publications and enable continued contact with languages being acquired. It will be available to teachers and students worldwide. Digilangua's digital initiatives for teachers and students will be powered by Magic EdTech's flagship technology solution, MagicBox™, an award-winning SaaS digital learning platform, accessed by over 6 million users globally.
Easing Education Delivery and Access
With close to a decade of success in publishing comprehensible novels, Digilangua seeks to broaden its scope by providing access to its learning materials via a digital platform. The company is an established leader in the publication of compelling, comprehensible novels. To date, their offerings include stories in Spanish, French, German, Italian, and English. The transition to MagicBox™ will allow the company to offer its libraries in a format compatible with multiple devices and operating systems. Digilangua will also continue to provide traditional physical textbooks for those who prefer them.
"We are very excited to be leveling up our business to provide a stable, workable platform for students and teachers,Magic Box is going to allow readers to better interact with the stories in our library."
Jennifer Degenhardt, co-owner at Digilangua.
MagicBox's eReader will allow interactive and personalized learning in addition to online/offline capabilities for a smooth learning experience. We are excited to partner with Digilangua and help them share their digital learning content globally," said Dipesh Jain, VP of Sales & Marketing at Magic Edtech.
About Magic Edtech
Magic EdTech is a New York-based technology company with over 30 years of Education experience. Its flagship platform, MagicBox™, is focused on creating and conceptualizing digital learning solutions for K-12 and higher education. The platform is being used by over 6 million students worldwide.
Digilangua is an online platform offering comprehensible novels with accompanying audio geared towards readers learning second languages. Novels are written with level-appropriate language and grammar, focusing on the repetition of both to aid in learning. An up-and-coming company, Digilangua has readership all over the world.
GoReact | November 17, 2022
GoReact today announced its expansion into the K-12 education market and the availability of its video feedback platform for school districts across the U.S. The formal expansion comes after a limited pilot with select school districts, which used GoReact’s platform to support teacher growth and development.
“Our platform has become a standard part of the higher education tech stack over the last decade, especially in new teacher development, and we’re thrilled to extend the benefits of our platform to K-12 districts nationwide,We all need to do more to support the incredible teachers shouldering ever-heavier burdens. GoReact empowers districts to better support teacher induction, growth and development.”
Ken Meyers, GoReact’s founder and CEO.
GoReact’s proprietary video feedback platform will help K-12 school districts offer teachers more support through:
Supporting induction programs by enabling new teachers to increase practice, model instruction, and receive targeted and visual feedback.
Fostering professional learning and development by tailoring feedback and empowering teachers to set measurable goals.
Onboarding unlicensed tutors and teachers of record by expediting time to proficiency with video observation.
Encouraging self-reflection by empowering teachers to watch videos of themselves teaching.
Engaging in teams through PLC collaboration on practices prioritized by the school or district.
Improving instructional leadership to maximize the educational impact of every minute spent in the classroom.
I love GoReact for teacher observations,” said Ann Stark, Mentor Teacher at Foothill Consortium California Teacher Induction Program.Having our beginning teachers actually see themselves teaching and then getting to provide comments on their areas of strength or growth is very powerful. With entry into the K-12 sector, GoReact is planning a comprehensive product roadmap geared toward the unique and evolving needs of K-12 education. GoReact already provides data security safeguards, including compliance with FERPA and COPPA, for its best-in-class video feedback platform. GoReact also integrates with all LTI-compliant learning management systems.
GoReact is reshaping education by humanizing and accelerating skills-based learning. More than 800 colleges, universities, and K-12 districts worldwide use GoReact to facilitate scalable video observation, coaching and assessment for rapid skill development. With simple, interactive tools for collaborative learning and personalized feedback, GoReact helps all learners demonstrate skill competency with greater human connection and engagement.